Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors
OPEN TO ACCRUAL
I/II
NCT06541262
bdenardo@BrownHealth.org
